(b)(4).Device evaluated by mfr: it is indicated that the device will not be returned for evaluation.A review of the batch history, historical trending, and similar complaint trending review for the product family will be conducted.If there is any further relevant information from that review, a supplemental medwatch will be filed.(b)(4).
|
It was reported that a hemostasis valve leak occurred with a subsequent drop in hemoglobin.A left atrial appendage (laa) closure procedure was performed.A watchman access system was advanced to the laa.The physician was able to close the hemostasis valve; however, back-bleed still occurred.When the pigtail was in-situ the backbleed was noted to be worse.The valve was tightened around the pigtail, but the backbleed continued.The physician blocked the valve as much as he could and continued the procedure with this device.A 33mm watchman laa closure device was successfully implanted.There were no patient complications during the procedure.The following day during a routine hemoglobin check it was noted that the patient's hemoglobin had dropped by almost 10%.No additional treatment was required and no further patient complications were reported.
|